Atea Historical Income Statement
| AVIR Stock | USD 3.76 0.09 2.34% |
Historical analysis of Atea PharmaceuticalsI income statement accounts such as Interest Income of 30.7 M, Depreciation And Amortization of 436.8 K or Interest Expense of 13.5 M can show how well Atea PharmaceuticalsInc performed in making a profits. Evaluating Atea PharmaceuticalsI income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Atea PharmaceuticalsI's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Atea PharmaceuticalsInc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Atea PharmaceuticalsInc is a good buy for the upcoming year.
Atea |
About Atea Income Statement Analysis
Atea PharmaceuticalsInc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Atea PharmaceuticalsI shareholders. The income statement also shows Atea investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Atea PharmaceuticalsI Income Statement Chart
Atea PharmaceuticalsInc Income Statement is one of the three primary financial statements used for reporting Atea's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Atea PharmaceuticalsInc revenue and expense. Atea PharmaceuticalsI Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Atea PharmaceuticalsI's Net Interest Income is relatively stable compared to the past year. As of 04/16/2024, Interest Income is likely to grow to about 30.7 M, while Other Operating Expenses is likely to drop slightly above 108.5 M. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Atea PharmaceuticalsInc. It is also known as Atea PharmaceuticalsI overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Atea PharmaceuticalsI's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Atea PharmaceuticalsInc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Atea PharmaceuticalsI's Net Interest Income is relatively stable compared to the past year. As of 04/16/2024, Interest Income is likely to grow to about 30.7 M, while Other Operating Expenses is likely to drop slightly above 108.5 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 213K | 11.2M | 29.2M | 30.7M | Net Interest Income | 213K | 11.2M | 29.2M | 30.7M |
Atea PharmaceuticalsI income statement Correlations
Click cells to compare fundamentals
Atea PharmaceuticalsI Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Atea PharmaceuticalsI income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | 574K | 83K | 213K | 11.2M | 29.2M | 30.7M | |
| Interest Income | 574K | 83K | 213K | 11.2M | 29.2M | 30.7M | |
| Selling General Administrative | 4.4M | 21.6M | 45.8M | 48.7M | 49.9M | 31.8M | |
| Other Operating Expenses | 14.6M | 59.7M | 213.0M | 130.7M | 164.2M | 108.5M | |
| Operating Income | (14.6M) | (11.0M) | 138.4M | (130.7M) | (164.2M) | (156.0M) | |
| Net Income From Continuing Ops | (14.0M) | (10.9M) | 121.2M | (115.9M) | (136.0M) | (129.2M) | |
| Ebit | (14.6M) | (11.0M) | 138.4M | (130.7M) | (164.2M) | (156.0M) | |
| Research Development | 10.2M | 38.0M | 167.2M | 81.9M | 114.2M | 76.7M | |
| Ebitda | (14.6M) | (11.0M) | 138.4M | (130.4M) | (163.7M) | (155.6M) | |
| Total Operating Expenses | 14.6M | 59.7M | 213.0M | 130.7M | 163.7M | 108.4M | |
| Income Before Tax | (14.0M) | (10.9M) | 138.6M | (119.5M) | (134.9M) | (128.2M) | |
| Total Other Income Expense Net | 574K | 83K | 213K | 11.2M | 29.2M | 30.7M | |
| Net Income Applicable To Common Shares | (14.0M) | (10.9M) | 121.2M | (115.9M) | (104.3M) | (99.1M) | |
| Net Income | (13.5M) | (10.9M) | 121.2M | (115.9M) | (136.0M) | (129.2M) | |
| Income Tax Expense | (574K) | (83K) | 17.4M | (3.6M) | 1.0M | 967.1K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atea PharmaceuticalsI in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atea PharmaceuticalsI's short interest history, or implied volatility extrapolated from Atea PharmaceuticalsI options trading.
Pair Trading with Atea PharmaceuticalsI
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.Moving against Atea Stock
| 0.7 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.58 | IVA | Inventiva Sa | PairCorr |
| 0.45 | FBRX | Forte Biosciences Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Atea PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea PharmaceuticalsInc to buy it.
The correlation of Atea PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Atea Stock analysis
When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (1.63) | Revenue Per Share 2.31 | Quarterly Revenue Growth 2.952 | Return On Assets (0.12) |
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.